FAST NEWS: Brii Bioscience shares rise on favorable hepatitis B data
The latest: Brii Biosciences Ltd. (2137.HK) said Wednesday that a study for its BRII-179 product to treat hepatitis B has shown favorable results in inducing functional immune responses. Looking up: The company…
